Regulation & law · 01/10/2019Updated: 10/17/2026 · 1 min read

Siemens Healthcare Diagnostics, Inc. Granted DEA Registration for Bulk Manufacturing of Controlled Substances

Summary

The Drug Enforcement Administration (DEA) has approved the registration of Siemens Healthcare Diagnostics, Inc. as a bulk manufacturer of various classes of schedule I and II controlled substances, following applications submitted by the company.

Original source language: Federal Register — Justice DepartmentOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Regulation & law · 9/14/2026

Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.

Cambrex High Point, Inc. has submitted an application to the U.S. government to be registered as a bulk manufacturer of controlled substances, a key step in the production and distribution of certain medications. The company is seeking to manufacture basic classes of controlled substances, as outlined in the accompanying SUPPLEMENTARY INFORMATION.

Read summary →

Regulation & law · 9/8/2026

Fresenius Kabi USA, LLC Seeks Registration as Controlled Substance Importer

Fresenius Kabi USA, LLC has submitted an application to the U.S. government to be registered as an importer of controlled substances, including basic classes of medications. The company aims to import these controlled substances for distribution in the United States.

Read summary →

Regulation & law · 9/14/2026

Irvine Labs, Inc. Applies for Controlled Substances Importer Registration

Irvine Labs, Inc. has submitted a request to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

AndersonBrecon, Inc DBA PCI Pharma Services Seeks Registration as Controlled Substance Importer

AndersonBrecon, Inc DBA PCI Pharma Services has submitted an application to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

Cambrex High Point, Inc. Seeks Registration as Controlled Substance Importer

Cambrex High Point, Inc. has submitted a request to the government to be registered as an importer of controlled substances, a move that could impact the pharmaceutical industry.

Read summary →

Regulation & law · 9/8/2026

Fisher Clinical Services, Inc. Seeks Registration as Controlled Substance Importer

Fisher Clinical Services, Inc. has submitted an application to the U.S. government to be registered as an importer of controlled substances, a move that could potentially impact the pharmaceutical industry.

Read summary →